<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00377806</url>
  </required_header>
  <id_info>
    <org_study_id>CVOL458UDE01</org_study_id>
    <nct_id>NCT00377806</nct_id>
  </id_info>
  <brief_title>Topical Diclofenac Gel in Patients With Superficial Inflammation of the Veins</brief_title>
  <official_title>A One Week, Double-Blind, Adaptive, Randomized, Multicenter Study to Compare the Efficacy, Safety and Tolerability of Topical Diclofenac Gel Versus Placebo in Patients With Superficial Thrombophlebitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Novartis</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Novartis</source>
  <brief_summary>
    <textblock>
      This study will assess the efficacy, safety and tolerability of topically administered
      diclofenac gel versus placebo with respect to the symptom score (pain, temperature and size
      of erythema along the superficial vein)
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2003</start_date>
  <completion_date type="Actual">September 2006</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The area under the curve (AUC) of the symptom score (pain, temperature and size of erythema along the superficial vein)</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient's global assessment of drug effect at each visit</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physician's global assessment of drug effect at each visit</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AUC of assessment of pain (visual analog scale) between treatment day 1 and day 5</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AUC of assessment of inflammatory area of the superficial thrombophlebitis between treatment day 1 and 5</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AUC of assessment of temperature of inflammatory area around superficial thrombophlebitis between treatment day 1 and 5</measure>
  </secondary_outcome>
  <enrollment>200</enrollment>
  <condition>Superficial Thrombophlebitis of the Upper Limb</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Diclofenac gel</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with indication of topical treatment for inflammatory, painful superficial
             thrombophlebitis of the upper limb

          -  Spontaneous or iatrogenic superficial thrombophebitis of the upper limb

        Exclusion Criteria:

          -  Hypersensitivity to the study drug, to actylsalicyclic acid and other non-steroidal
             antirheumatic agents and to the ingredients of the gel

          -  Paitents who had developed asthma, skin reactions or acute rhinitis to acetylsalicylic
             acid or other non-steroidal antirheumatic agents in the past

          -  Therapy with varicose vein remedies, antithrombotic or antiphlogistic agents as well
             as corticosteroids for more than 7 days prior to study start

          -  Acute deep vein thrombosis and thrombophlebitis extending into other deep veins

        Other protocol-defined exclusion criteria may apply
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Novartis Pharmaceuticals</last_name>
    <role>Principal Investigator</role>
    <affiliation>Novartis Pharmaceuticals</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Novartis</name>
      <address>
        <city>NÃ¼rnberg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>December 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 15, 2006</study_first_submitted>
  <study_first_submitted_qc>September 15, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 18, 2006</study_first_posted>
  <last_update_submitted>December 7, 2007</last_update_submitted>
  <last_update_submitted_qc>December 7, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 10, 2007</last_update_posted>
  <keyword>Superficial thrombophlebitis, diclofenac gel, non steroidal antiinflammatory drugs</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thrombophlebitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diclofenac</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

